Literature DB >> 17056503

Harboring of particulate allergens within secretory compartments by mast cells following IgE/FcepsilonRI-lipid raft-mediated phagocytosis.

Jeoung-Sook Shin1, Christopher P Shelburne, Cong Jin, E Ann LeFurgey, Soman N Abraham.   

Abstract

Although much is known regarding the exocytic responses of mast cells following allergen/IgE-mediated activation, little is currently known of the fate of the activating allergens, many of which are particles. We have found that IgE-bound particulate allergens were phagocytosed by activated mast cells in a lipid raft-dependent manner. The nascent allergen-containing phagosomes were found to transform into granule compartments by acquiring VAMP7 and serotonin and exhibited the capacity to empty their contents upon mast cell activation. When allergen-harboring mast cells were stimulated, the intracellular allergens were expelled intact and shown to activate adjacent mast cells. This capacity of mast cells to phagocytose and retain whole and antigenically intact allergens could potentially contribute to the course of inflammatory diseases such as asthma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17056503     DOI: 10.4049/jimmunol.177.9.5791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Particulate allergens potentiate allergic asthma in mice through sustained IgE-mediated mast cell activation.

Authors:  Cong Jin; Christopher P Shelburne; Guojie Li; Erin N Potts; Kristina J Riebe; Gregory D Sempowski; W Michael Foster; Soman N Abraham
Journal:  J Clin Invest       Date:  2011-03       Impact factor: 14.808

2.  Indirect involvement of allergen-captured mast cells in antigen presentation.

Authors:  Taku Kambayashi; Jan D Baranski; Rebecca G Baker; Tao Zou; Eric J Allenspach; Jonathan E Shoag; Peter L Jones; Gary A Koretzky
Journal:  Blood       Date:  2007-11-21       Impact factor: 22.113

3.  Serum IgE clearance is facilitated by human FcεRI internalization.

Authors:  Alexandra M Greer; Nan Wu; Amy L Putnam; Prescott G Woodruff; Paul Wolters; Jean-Pierre Kinet; Jeoung-Sook Shin
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

Review 4.  Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?

Authors:  Taku Kambayashi; Terri M Laufer
Journal:  Nat Rev Immunol       Date:  2014-10-17       Impact factor: 53.106

5.  Antigen-conjugated human IgE induces antigen-specific T cell tolerance in a humanized mouse model.

Authors:  Günther Baravalle; Alexandra M Greer; Taylor N LaFlam; Jeoung-Sook Shin
Journal:  J Immunol       Date:  2014-03-07       Impact factor: 5.422

Review 6.  Statin drugs, metabolic pathways, and asthma: a therapeutic opportunity needing further research.

Authors:  Amir A Zeki; Nicholas J Kenyon; Tzipora Goldkorn
Journal:  Drug Metab Lett       Date:  2011-01

7.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

8.  Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation.

Authors:  Taku Kambayashi; Eric J Allenspach; John T Chang; Tao Zou; Jonathan E Shoag; Steven L Reiner; Andrew J Caton; Gary A Koretzky
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Iron supplementation decreases severity of allergic inflammation in murine lung.

Authors:  Laura P Hale; Erin Potts Kant; Paula K Greer; W Michael Foster
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.